Fair Value Measurements (Tables)

3 Months Ended

Mar. 29, 2024

Fair Value Disclosures [Abstract]

Schedule of financial assets and liabilities at carrying and fair value

A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):

	Quoted Prices in Active Market (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
March 29, 2024:
Liabilities:
Cross-currency swap derivative contract	$	—	$	—	$	—	$	—
Deferred compensation plans	$	—	$	22.9	$	—	$	22.9
Contingent consideration	$	—	$	—	$	3.8	$	3.8
December 31, 2023:
Liabilities:
Cross-currency swap derivative contract	$	—	$	3.3	$	—	$	3.3
Deferred compensation plans	$	—	$	21.4	$	—	$	21.4
Contingent consideration	$	—	$	—	$	3.8	$	3.8

The carrying amounts and fair values of the Company’s financial instruments were as follows ($ in millions):

	March 29, 2024				December 31, 2023
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Liabilities:
Contingent consideration	$	3.8	$	3.8	$	3.8	$	3.8
Cross-currency swap derivative contract	$	—	$	—	$	3.3	$	3.3
Convertible senior notes due 2028	$	487.6	$	441.8	$	486.9	$	455.7
Convertible senior notes due 2025	$	115.5	$	135.8	$	115.3	$	145.1
Other debt	$	902.9	$	902.9	$	911.2	$	911.2